1. Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
- Author
-
Priyamvada Acharya, Kevin Wiehe, Kevin O. Saunders, Barton F. Haynes, and Gregory D. Sempowski
- Subjects
medicine.medical_specialty ,Economic growth ,COVID-19 Vaccines ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Pneumonia, Viral ,Biology ,Antibodies, Viral ,Article ,General Biochemistry, Genetics and Molecular Biology ,Betacoronavirus ,03 medical and health sciences ,0302 clinical medicine ,Pandemic ,medicine ,Animals ,Humans ,Intersectoral Collaboration ,Pandemics ,030304 developmental biology ,AIDS Vaccines ,0303 health sciences ,Government ,SARS-CoV-2 ,Pandemic preparedness ,Public health ,Viral Vaccine ,Antibodies, Monoclonal ,COVID-19 ,Viral Vaccines ,Antibodies, Neutralizing ,COVID-19 Drug Treatment ,Coronavirus Infections ,030217 neurology & neurosurgery - Abstract
The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises, necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic, and private partnerships working together to rapidly develop vaccine and antibody countermeasures. Many of the technologies being used are derived from prior government-academic partnerships for response to other emerging infections.
- Published
- 2020
- Full Text
- View/download PDF